IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 37 filers reported holding IRADIMED CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $846,000 | +7.6% | 19,247 | +7.7% | 0.00% | – |
Q1 2024 | $786,000 | +583.5% | 17,866 | +638.6% | 0.00% | – |
Q4 2023 | $115,000 | +139.6% | 2,419 | +122.5% | 0.00% | – |
Q3 2023 | $48,000 | +108.7% | 1,087 | +123.2% | 0.00% | – |
Q2 2023 | $23,000 | -37.8% | 487 | -48.4% | 0.00% | – |
Q1 2023 | $37,000 | -5.1% | 943 | -32.7% | 0.00% | – |
Q4 2022 | $39,000 | +225.0% | 1,402 | +260.4% | 0.00% | – |
Q3 2022 | $12,000 | +20.0% | 389 | +22.3% | 0.00% | – |
Q2 2022 | $10,000 | -65.5% | 318 | -51.5% | 0.00% | – |
Q1 2022 | $29,000 | -65.5% | 655 | -63.7% | 0.00% | – |
Q4 2021 | $84,000 | +265.2% | 1,805 | +175.6% | 0.00% | – |
Q3 2021 | $23,000 | +64.3% | 655 | +37.6% | 0.00% | – |
Q2 2021 | $14,000 | 0.0% | 476 | -13.0% | 0.00% | – |
Q1 2021 | $14,000 | +55.6% | 547 | +47.0% | 0.00% | – |
Q4 2020 | $9,000 | +800.0% | 372 | +1140.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | -66.7% | 30 | -77.3% | 0.00% | – |
Q1 2020 | $3,000 | 0.0% | 132 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | +200.0% | 132 | +388.9% | 0.00% | – |
Q3 2019 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
Q2 2019 | $1,000 | -80.0% | 27 | -84.7% | 0.00% | – |
Q1 2019 | $5,000 | -85.3% | 177 | -87.0% | 0.00% | – |
Q4 2018 | $34,000 | -33.3% | 1,366 | 0.0% | 0.00% | – |
Q3 2018 | $51,000 | +104.0% | 1,366 | +12.3% | 0.00% | – |
Q2 2018 | $25,000 | +8.7% | 1,216 | -25.0% | 0.00% | – |
Q1 2018 | $23,000 | -8.0% | 1,622 | 0.0% | 0.00% | – |
Q4 2017 | $25,000 | +56.2% | 1,622 | -0.4% | 0.00% | – |
Q3 2017 | $16,000 | -11.1% | 1,628 | -23.4% | 0.00% | – |
Q2 2017 | $18,000 | +1700.0% | 2,125 | +1886.0% | 0.00% | – |
Q1 2017 | $1,000 | -97.7% | 107 | -97.2% | 0.00% | – |
Q4 2016 | $43,000 | +13.2% | 3,867 | +72.0% | 0.00% | – |
Q3 2016 | $38,000 | +90.0% | 2,248 | +144.6% | 0.00% | – |
Q2 2016 | $20,000 | +25.0% | 919 | +10.3% | 0.00% | – |
Q1 2016 | $16,000 | +300.0% | 833 | +427.2% | 0.00% | – |
Q3 2015 | $4,000 | 0.0% | 158 | -14.6% | 0.00% | – |
Q2 2015 | $4,000 | – | 185 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
RK Capital | 211,325 | $4,512,000 | 2.03% |
Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |